MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.20−0.09 (-3.93%)
Close on Nov 13, 2026Market cap $140.14MP/E –Yield –
MacroGenics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MacroGenics's enterprise value was $33.75M on Nov 11, 2026, against $16.66M a year earlier. Over the last 5 years it ranged from -$103.06M to $1.01B, with a median of $154.87M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $33.75M | +55.4% |
| 2025 | Dec 31, 2025 | $21.72M | -10.8% |
| 2024 | Dec 31, 2024 | $24.36M | -95.2% |
| 2023 | Dec 29, 2023 | $506.82M | +54.3% |
| 2022 | Dec 30, 2022 | $328.42M | -58.6% |
| 2021 | Dec 31, 2021 | $792.61M | -26.8% |
| 2020 | Dec 31, 2020 | $1.08B | +188.2% |
| 2019 | Dec 31, 2019 | $375.59M | +12.2% |
| 2018 | Dec 31, 2018 | $334.74M | -45.0% |
| 2017 | Dec 29, 2017 | $608.45M | +1.1% |
| 2016 | Dec 30, 2016 | $601.68M | -13.4% |
| 2015 | Dec 31, 2015 | $694.90M | -12.6% |
| 2014 | Dec 31, 2014 | $794.78M | +3116.5% |
| 2013 | Dec 31, 2013 | $24.71M | – |
See a number that looks wrong?